Avenue Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:49Y Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
30 Sep 24	Buy€1,120	Jay Kranzler	Individual		500	€2.24
11 Dec 23	Sell€80,570	Robert Davidow	Individual		8,226.65	€10.47

Insider Buying: 49Y insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 737.5%.

Top 18 shareholders own 13.88% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.24%	Armistice Capital LLC	75,000	€155.1k	0%	no data
3.3%	Fortress Biotech, Inc.	47,299	€97.8k	13.2%	no data
2.61%	Sabby Management, LLC	37,394	€77.3k	318%	0.78%
1.2%	Robert Davidow	17,206	€35.6k	-1.48%	no data
0.77%	Moss Adams Wealth Advisors LLC	11,000	€22.7k	0%	no data
0.33%	Lindsay Rosenwald	4,671	€9.7k	0%	no data
0.22%	Tower Research Capital Europe Limited	3,205	€6.6k	2,620%	no data
0.049%	Geode Capital Management, LLC	695	€1.4k	0%	no data
0.047%	UBS Asset Management AG	673	€1.4k	0%	no data
0.043%	Jay Kranzler	620	€1.3k	417%	no data
0.043%	The Vanguard Group, Inc.	617	€1.3k	0%	no data
0.0084%	Neil Herskowitz	120	€248.1	0.84%	no data
0.0043%	Wells Fargo & Company, Securities and Brokerage Investments	61	€126.1	1.67%	no data
0.0031%	Curtis Oltmans	44	€90.9	0%	no data
0.00056%	Royal Bank of Canada, Banking & Securities Investments	8	€16.6	14.3%	no data
0.00056%	EMFO, LLC	8	€16.6	14.3%	no data
0.00049%	Bank of America Corporation, Asset Management Arm	7	€14.5	0%	no data
0.00007%	JPMorgan Chase & Co, Brokerage and Securities Investments	1	€2.1	0%	no data